OpenVSafe by OpenVAERS
Search V-safe

58L-54130-65601

2 vaccinations 3 coded responses 15 check-ins 3 free-text entries 0 call cases
Sex
Male
Age at first dose
12-15
ZIP prefix
983 / WA
Registered
2021-11-16
Relationship
Child or adolescent in my care
Guardian
9QD-54200-93082
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-02
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-16
    Registered in v-safe
  3. 2021-11-19
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  4. 2021-11-23
    Dose 2 — Pfizer-BioNTech
  5. 2021-11-24
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-11-25
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-11-26
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-11-27
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-11-28
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-11-29
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-11-30
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  12. 2021-12-07
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2021-12-14
    Survey response — day 21, dose 2, dependent
    MedDRA: Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-12-26
    Survey response — day 28, dose 2, dependent
    MedDRA: Lacrimation increased, Rhinorrhoea — Feeling: Fair
    Free text: Runny nose, watery eyes
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-12-28
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-01-04
    Survey response — day 42, dose 2, dependent
    MedDRA: Cough, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school
    Free text: Cold symptoms & cough
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-02-22
  18. 2022-05-29

Vaccinations

DoseDateManufacturerCo-administered
12021-11-02Pfizer-BioNTech No
22021-11-23Pfizer-BioNTech No

Free text

Release 10 — day 21, dose 2, dependent

2021-12-14

Symptoms: Sore throat

Release 10 — day 28, dose 2, dependent

2021-12-26

Symptoms: Runny nose, watery eyes

Release 10 — day 42, dose 2, dependent

2022-01-04

Symptoms: Cold symptoms & cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDLacrimation increased · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release